{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:49:02Z","timestamp":1792180142055,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40291-022-00588-0","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T12:04:43Z","timestamp":1651061083000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CAH-X Syndrome: Genetic and Clinical Profile"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-8898","authenticated-orcid":false,"given":"Paola","family":"Concolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"588_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/gbe\/evs121","volume":"5","author":"Z B\u00e1nlaki","year":"2013","unstructured":"B\u00e1nlaki Z, Szab\u00f3 JA, Szil\u00e1gyi \u00c1, Pat\u00f3cs A, Proh\u00e1szka Z, F\u00fcst G, et al. Intraspecific evolution of human RCCX copy number variation traced by haplotypes of the CYP21A2 gene. Genome Biol Evol. 2013;5:98\u2013112.","journal-title":"Genome Biol Evol"},{"key":"588_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrg1489","volume":"5","author":"R Horton","year":"2004","unstructured":"Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5:889\u201399.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"588_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.709758","volume":"30","author":"C Carrozza","year":"2021","unstructured":"Carrozza C, Foca L, De Paolis E, Concolino P. Genes and pseudogenes: complexity of the RCCX locus and disease. Front Endocrinol (Lausanne). 2021;30(12): 709758.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"588_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/ejhg.2017.38","volume":"25","author":"M Doleschall","year":"2017","unstructured":"Doleschall M, Luczay A, Koncz K, Hadzsiev K, Erhardt \u00c9, Szil\u00e1gyi \u00c1, et al. A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics. Eur J Hum Genet. 2017;25:702\u201310.","journal-title":"Eur J Hum Genet"},{"key":"588_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/gene.2012.29","volume":"13","author":"Z B\u00e1nlaki","year":"2012","unstructured":"B\u00e1nlaki Z, Doleschall M, Rajczy K, Fust G, Szil\u00e1gyi A. Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes. Genes Immun. 2012;13:530\u20135.","journal-title":"Genes Immun"},{"key":"588_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, et al. Congenital adrenal hyperplasia: current insights in pathophysiology, diagnostics, and management. Endocr Rev. 2022;43:91\u2013159.","journal-title":"Endocr Rev"},{"key":"588_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40291-018-0319-y","volume":"22","author":"P Concolino","year":"2018","unstructured":"Concolino P, Costella A. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene. Mol Diagn Ther. 2018;22:261\u201380.","journal-title":"Mol Diagn Ther"},{"key":"588_CR8","first-page":"17","volume":"42","author":"Y Higashi","year":"1988","unstructured":"Higashi Y, Tanae A, Inoue H, Fujii-Kuriyama Y. Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency. Am J Hum Genet. 1988;42:17\u201325.","journal-title":"Am J Hum Genet"},{"key":"588_CR9","doi-asserted-by":"publisher","first-page":"10796","DOI":"10.1073\/pnas.92.23.10796","volume":"92","author":"MT Tusi\u00e9-Luna","year":"1995","unstructured":"Tusi\u00e9-Luna MT, White PC. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci USA. 1995;92:10796\u2013800.","journal-title":"Proc Natl Acad Sci USA"},{"key":"588_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12020-015-0731-6","volume":"50","author":"H Falhammar","year":"2015","unstructured":"Falhammar H, Wedell A, Nordenstr\u00f6m A. Biochemical and genetic diagnosis of 21-hydroxylase deficiency. Endocrine. 2015;50:306\u201314.","journal-title":"Endocrine"},{"key":"588_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"Falhammar H, Thor\u00e9n M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine. 2012;41:355\u201373.","journal-title":"Endocrine"},{"key":"588_CR12","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-18-0712","volume":"180","author":"A Nordenstr\u00f6m","year":"2019","unstructured":"Nordenstr\u00f6m A, Falhammar H. Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Eur J Endocrinol. 2019;180:R127\u201345.","journal-title":"Eur J Endocrinol"},{"key":"588_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11154-008-9097-x","volume":"10","author":"PW Speiser","year":"2009","unstructured":"Speiser PW. Nonclassic adrenal hyperplasia. Rev Endocr Metab Disord. 2009;10:77\u201382.","journal-title":"Rev Endocr Metab Disord"},{"key":"588_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2010-625105","volume":"2010","author":"SF Witchel","year":"2010","unstructured":"Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2010;2010: 625105.","journal-title":"Int J Pediatr Endocrinol"},{"key":"588_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2018.11.037","volume":"111","author":"LG Gomes","year":"2019","unstructured":"Gomes LG, Bachega TASS, Mendonca BB. Classic congenital adrenal hyperplasia and its impact on reproduction. Fertil Steril. 2019;111:7\u201312.","journal-title":"Fertil Steril"},{"key":"588_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4161\/19336918.2014.994893","volume":"9","author":"U Valcourt","year":"2015","unstructured":"Valcourt U, Alcaraz LB, Exposito JY, Lethias C, Bartholin L. Tenascin-X: beyond the architectural function. Cell Adhes Migr. 2015;9:154\u201365.","journal-title":"Cell Adhes Migr"},{"key":"588_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers\u2013Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175:8\u201326.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"588_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1086\/376564","volume":"73","author":"MC Zweers","year":"2003","unstructured":"Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M, et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers\u2013Danlos syndrome. Am J Hum Genet. 2003;73:214\u20137.","journal-title":"Am J Hum Genet"},{"key":"588_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/dvdy.220","volume":"250","author":"C Gensemer","year":"2021","unstructured":"Gensemer C, Burks R, Kautz S, Judge DP, Lavallee M, Norris RA. Hypermobile Ehlers\u2013Danlos syndromes: complex phenotypes, challenging diagnoses, and poorly understood causes. Dev Dyn. 2021;250:318\u201344.","journal-title":"Dev Dyn"},{"key":"588_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng0997-104","volume":"17","author":"GH Burch","year":"1997","unstructured":"Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, et al. Tenascin-X deficiency is associated with Ehlers\u2013Danlos syndrome. Nat Genet. 1997;17:104\u20138.","journal-title":"Nat Genet"},{"key":"588_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612497","volume":"11","author":"WL Miller","year":"2021","unstructured":"Miller WL. Tenascin-X-discovery and early research. Front Immunol. 2021;11: 612497.","journal-title":"Front Immunol"},{"key":"588_CR22","doi-asserted-by":"publisher","first-page":"E379","DOI":"10.1210\/jc.2012-3148","volume":"98","author":"DP Merke","year":"2013","unstructured":"Merke DP, Chen W, Morissette R, Xu Z, Van Ryzin C, Sachdev V, et al. Tenascin-X haploinsufficiency associated with Ehlers\u2013Danlos syndrome in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2013;98:E379\u201387.","journal-title":"J Clin Endocrinol Metab"},{"key":"588_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000481911","volume":"89","author":"WL Miller","year":"2018","unstructured":"Miller WL, Merke DP. Tenascin-X, congenital adrenal hyperplasia, and the CAH-X syndrome. Horm Res Paediatr. 2018;89:352\u201361.","journal-title":"Horm Res Paediatr"},{"key":"588_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur J Hum Genet. 2020;28:1341\u201367.","journal-title":"Eur J Hum Genet"},{"key":"588_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"Merke DP, Auchus RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 2020;383:1248\u201361.","journal-title":"N Engl J Med"},{"key":"588_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2350-10-72","volume":"10","author":"P Concolino","year":"2009","unstructured":"Concolino P, Mello E, Minucci A, Giardina E, Zuppi C, Toscano V, et al. A new CYP21A1P\/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. BMC Med Genet. 2009;10:72.","journal-title":"BMC Med Genet"},{"key":"588_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1373\/clinchem.2011.174037","volume":"58","author":"W Chen","year":"2012","unstructured":"Chen W, Xu Z, Sullivan A, Finkielstain GP, Van Ryzin C, Merke DP, et al. Junction site analysis of chimeric CYP21A1P\/CYP21A2 genes in 21-hydroxylase deficiency. Clin Chem. 2012;58:421\u201330.","journal-title":"Clin Chem"},{"key":"588_CR28","doi-asserted-by":"publisher","first-page":"E1143","DOI":"10.1210\/jc.2015-2232","volume":"100","author":"R Morissette","year":"2015","unstructured":"Morissette R, Chen W, Perritt AF, Dreiling JL, Arai AE, Sachdev V, et al. Broadening the spectrum of Ehlers Danlos syndrome in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100:E1143\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"588_CR29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa002939","volume":"345","author":"J Schalkwijk","year":"2001","unstructured":"Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, et al. A recessive form of the Ehlers\u2013Danlos syndrome caused by tenascin-X deficiency. N Engl J Med. 2001;345:1167\u201375.","journal-title":"N Engl J Med"},{"key":"588_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/humu.23028","volume":"37","author":"W Chen","year":"2016","unstructured":"Chen W, Perritt AF, Morissette R, Dreiling JL, Bohn MF, Mallappa A, et al. Ehlers\u2013Danlos syndrome caused by biallelic TNXB variants in patients with congenital adrenal hyperplasia. Hum Mutat. 2016;37:893\u20137.","journal-title":"Hum Mutat"},{"key":"588_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jmoldx.2019.06.001","volume":"21","author":"Q Lao","year":"2019","unstructured":"Lao Q, Brookner B, Merke DP. High-throughput screening for CYP21A1P-TNXA\/TNXB chimeric genes responsible for Ehlers\u2013Danlos syndrome in patients with congenital adrenal hyperplasia. J Mol Diagn. 2019;21:924\u201331.","journal-title":"J Mol Diagn"},{"key":"588_CR32","doi-asserted-by":"publisher","first-page":"dgaa199","DOI":"10.1210\/clinem\/dgaa199","volume":"105","author":"Y Gao","year":"2020","unstructured":"Gao Y, Lu L, Yu B, Mao J, Wang X, Nie M, et al. The prevalence of the chimeric TNXA\/TNXB gene and clinical symptoms of Ehlers\u2013Danlos syndrome with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2020;105:dgaa199.","journal-title":"J Clin Endocrinol Metab"},{"key":"588_CR33","doi-asserted-by":"publisher","first-page":"e2789","DOI":"10.1210\/clinem\/dgab033","volume":"106","author":"R Marino","year":"2021","unstructured":"Marino R, Garrido NP, Ramirez P, Notarist\u00e9fano G, Moresco A, Touzon MS, et al. Ehlers\u2013Danlos syndrome: molecular and clinical characterization of TNXA\/TNXB chimeras in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2021;106:e2789\u2013802.","journal-title":"J Clin Endocrinol Metab"},{"key":"588_CR34","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ygeno.2003.11.006","volume":"83","author":"HH Lee","year":"2004","unstructured":"Lee HH, Lee YJ, Lin CY. PCR-based detection of the CYP21 deletion and TNXA\/TNXB hybrid in the RCCX module. Genomics. 2004;83:944\u201350.","journal-title":"Genomics"},{"key":"588_CR35","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41431-021-00870-5","volume":"29","author":"Q Lao","year":"2021","unstructured":"Lao Q, Merke DP. Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras. Eur J Hum Genet. 2021;29:1047\u20138.","journal-title":"Eur J Hum Genet"},{"key":"588_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41431-021-00869-y","volume":"29","author":"S Baumgartner-Parzer","year":"2021","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. Reply to Lao Q and Merke DP. Eur J Hum Genet. 2021;29:1045\u20136.","journal-title":"Eur J Hum Genet"},{"key":"588_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1530\/EC-18-0031","volume":"7","author":"H Falhammar","year":"2018","unstructured":"Falhammar H, Claahsen-van der Grinten H, Reisch N, Slowikowska-Hilczer J, Nordenstr\u00f6m A, Roehle R, Bouvattier C, dsd-LIFE Group, et al. Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study. Endocr Connect. 2018;7:466\u201378.","journal-title":"Endocr Connect"},{"key":"588_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1210\/js.2019-00200","volume":"3","author":"H Falhammar","year":"2019","unstructured":"Falhammar H, Fris\u00e9n L, Hirschberg AL, Nordenskj\u00f6ld A, Almqvist C, Nordenstr\u00f6m A. Increased risk of autoimmune disorders in 21-hydroxylase deficiency: a Swedish population-based national cohort study. J Endocr Soc. 2019;3:1039\u201352.","journal-title":"J Endocr Soc"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-022-00588-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T10:37:13Z","timestamp":1652351833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-022-00588-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1007\/s40291-022-00588-0","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"3 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors (PC and HF) declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}